We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-1.39%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33.8M
Cap. Flow
% of AUM
9.8%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$4.2M |
| 2 |
Procter & Gamble
PG
|
+$3.18M |
| 3 |
Apple
AAPL
|
+$2.96M |
| 4 |
Booking.com
BKNG
|
+$2.81M |
| 5 |
Diageo
DEO
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$3.37M |
| 2 |
NVIDIA
NVDA
|
+$3.35M |
| 3 |
On Holding
ONON
|
+$2.92M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$2.64M |
| 5 |
ASML
ASML
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Vanda Pharmaceuticals
VNDA
$314M
| $6.36K | ﹤0.01% |
1,472
+719
| +95% | +$4K |
|
|
KLRS
377
Kalaris Therapeutics
KLRS
$93.7M
| $6.27K | ﹤0.01% |
127
+74
| +140% | +$5.04K |
|
378
Acumen Pharmaceuticals
ABOS
$181M
| $6.15K | ﹤0.01% |
1,481
+943
| +175% | +$5.83K |
|
379
Monte Rosa Therapeutics
GLUE
$1.36B
| $6.13K | ﹤0.01% |
1,280
+633
| +98% | +$4.08K |
|
380
Enanta Pharmaceuticals
ENTA
$393M
| $6.12K | ﹤0.01% |
548
+272
| +99% | +$4.38K |
|
381
Immuneering
IMRX
$328M
| $5.75K | ﹤0.01% |
749
+366
| +96% | +$3.37K |
|
382
AtaiBeckley Inc
ATAI
$2.68B
| $5.49K | ﹤0.01% |
4,258
+2,083
| +96% | +$3.57K |
|
383
Foghorn Therapeutics
FHTX
$394M
| $5.37K | ﹤0.01% |
1,073
+525
| +96% | +$4.05K |
|
384
Sutro Biopharma
STRO
$353M
| $5.37K | ﹤0.01% |
155
+76
| +96% | +$3.31K |
|
385
Fate Therapeutics
FATE
$317M
| $5.36K | ﹤0.01% |
2,526
+1,236
| +96% | +$4.09K |
|
|
PSTX
386
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $5.3K | ﹤0.01% |
2,225
+1,088
| +96% | +$2.28K |
|
|
EGRX
387
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.27K | ﹤0.01% |
334
+162
| +94% | +$2.91K |
|
388
Quantum-Si Incorporated
QSI
$182M
| $5.19K | ﹤0.01% |
3,127
+1,534
| +96% | +$3.69K |
|
|
EXAI
389
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $5.16K | ﹤0.01% |
1,141
+565
| +98% | +$3.65K |
|
|
CMPS
390
Compass Pathways
CMPS
$1.97B
| $5.11K | ﹤0.01% |
690
+377
| +120% | +$3.34K |
|
|
TSVT
391
DELISTED
2seventy bio
TSVT
| $5.1K | ﹤0.01% |
1,300
+642
| +98% | +$4.21K |
|
392
ALX Oncology
ALXO
$278M
| $5.07K | ﹤0.01% |
1,056
+520
| +97% | +$2.82K |
|
|
ALLK
393
DELISTED
Allakos
ALLK
| $5.05K | ﹤0.01% |
2,225
+1,091
| +96% | +$4.05K |
|
|
GRCL
394
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $5.03K | ﹤0.01% |
1,748
+855
| +96% | +$3.13K |
|
395
Gossamer Bio
GOSS
$86.8M
| $4.81K | ﹤0.01% |
5,774
+4,523
| +362% | +$5.21K |
|
396
Invivyd
IVVD
$216M
| $4.79K | ﹤0.01% |
2,816
+1,381
| +96% | +$2.19K |
|
397
Omeros
OMER
$992M
| $4.73K | ﹤0.01% |
1,619
+795
| +96% | +$3.19K |
|
398
Stoke Therapeutics
STOK
$2.13B
| $4.46K | ﹤0.01% |
1,132
+553
| +96% | +$3.64K |
|
399
Texas Roadhouse
TXRH
$14.1B
| $4.23K | ﹤0.01% |
44
| – | – |
|
400
Cartesian Therapeutics
RNAC
$263M
| $4.17K | ﹤0.01% |
131
+64
| +96% | +$2.14K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2023 Portfolio in Review
As of Q3 2023, China Universal Asset Management Company held 466 positions worth $345M, up 6.5% from $324M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company deployed $33.8M of net new capital in Q3 2023, opening 14 new positions and adding to 365 existing holdings. Its largest new stake was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $3.37M trimmed.
- China Universal Asset Management Company's largest Q3 2023 buy was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
- China Universal Asset Management Company added most to Amazon in Q3 2023, an estimated $4.2M increase.
- China Universal Asset Management Company's biggest Q3 2023 reduction was TSMC, cutting an estimated $3.37M.
- China Universal Asset Management Company fully exited Carnival Corporation Ltd in Q3 2023, selling an estimated $2.64M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $345M portfolio in Q3 2023.
- China Universal Asset Management Company opened 14 new positions and closed 20 in Q3 2023.
- China Universal Asset Management Company's portfolio value rose 6.5% quarter-over-quarter to $345M.
Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.